GETTING TO THE HEART OF MEDICINE
(continued from page 21)
and modeling study. J Am Coll Cardiol. 2013;62:1002-12.
2
Ancona R, Pinto SC Epidemiology of aortic valve stenosis (AS) and of aortic
valve incompetence (AI): is the prevalence of AS/AI similar in different parts
of the world? Eur Soc of Cardiol. 2020;18(10)
3
Lung, B., et al., Decision-making in elderly patients with severe aortic stenosis:
why are so many denied surgery? Eur Heart J. 2005; 26(24): 2714-20.
4
Rubio Alverez V, Limon Lason R. Tricuspid commissurotomy by means of a
modified catheter. Arch Inst Cardiol Mex. 1955; 25(1): 57-69
5
Davis H. Catheter-mounted valve for temporary relief of aortic insufficiency.
Lancet 1965;285:250.
6
Semb BK, Tjonneland S, Stake G, Aabyholm G. Balloon valvulotomy of congential
pulmonary valve stenosis with tricuspid valve insufficiency. Cardiovasc
Radiol. 1979;2(4):239-241
7
Kan JS, White RI, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty:
a new method for treating congenital pulmonary valve stenosis. N Engl J Med.
1982;307(9):540-542.
8
Lock JE, Khalilullah M, Shrivastava S, et al. Percutaneous catheter commissurotomy
in rheumatic mitral stenosis. N Engl J Med 1985;313(24):1515-1518.
9
Cribier A, Savin T, Saoudi N, et al. Percutaneous transluminal valvuloplasty of
acquired aortic stenosis in elderly patients: an alternative to valve replacement?
Lancet. 1986;1(8472):63-67.
10
Andersen HR, Knusden LL, Hasenkam JM. Transluminal implantation of
artificial heart valves. Description of a new expandable aortic valve and initial
results with implantion by catheter technique in closed chest pigs. Eur Heart
J, 1992;13(5): 704-708
11
Cribier AG. The Odyssey of TAVR from concept to clinical reality. Tex Heart
Inst J. 2014; 41(2):125-30.
12
Eltchaninoff H, Nusimovici-Avadis D, Babaliaros V, et al. Five month study
of percutaneous heart valves in the systemic circulation of sheep using a novel
model of aortic insufficiency. EuroIntervention. 2006; 1(4):438-44.
13
Cribier A, Eltchaninoff H, Tron C, Bauer F,et al. Early experience with percutaneous
transcatheter implantation of heart valve prosthesis for the treatment
of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol.
2004; 43(4):698-703.
14
Leon MD, Smith CR, Mack M, et al. Transcatheter aortic valve implantation
for aortic stenosis in patients who cannot undergo surgery. N Eng J Med. 2010;
363(17):1597-1607
15
Leon MB, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk
Patients. The New England Journal of Medicine. 2016; 374(17):1609-
20.
16
Reardon MJ, et al. Surgical or transcatheter aortic-valve replacement in
intermediate-risk patients. The New England Journal of Medicine. 2017;
376(14):1321-1331.
17
Mack MJ, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable
Valve in Low-Risk Patients. The New England Journal of Medicine.
2019. 380(18):1695-1705.
18
Kenny D, Rhodes JF, Fleming GA, et al. 3-Year Outcomes of the Edwards SA-
PIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position
From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv.
2018;11(19):1920‐1929.
19
Khan JM, Rogers T, Schenke WH, et al. Intentional Laceration of the Anterior
Mitral Valve Leaflet to Prevent Left Ventricular Outflow Tract Obstruction
During Transcatheter Mitral Valve Replacement: Pre-Clinical Findings. JACC
Cardiovasc Interv. 2016;9(17):1835‐1843.
Dr. Brian Kaebnick is an interventional cardiologist with Louisville Cardiology Group
at Baptist Hospital Louisville.
STAY
Connected
www.glms.org
facebook.com/Greater-Louisville-Medical-Society
@LouMedSociety
@LouMedSociety
linkedin.com/groups/Greater-Louisville-Medical-Society
22 LOUISVILLE MEDICINE